바이오소재 창상 피복재 시장 보고서(2026년)
Biomaterial Wound Dressing Global Market Report 2026
상품코드 : 1939348
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,707,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,694,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,682,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

생체 재료 창상 피복재 시장 규모는 최근 현저한 성장을 달성하고 있습니다. 2025년 61억 8,000만 달러에서 2026년에는 66억 5,000만 달러로, CAGR 7.6%로 확대할 전망입니다. 지난 수년간의 성장에는 화상 및 외상성 손상 발생률 증가, 만성 및 당뇨성 상처로 인한 입원 환자 수 증가, 하이드로겔 및 알긴산 드레싱 기술의 조기 도입, 감염 예방 및 수분 균형 치유에 대한 관심 증가, 병원 및 클리닉의 상처 관리 서비스 확대 등이 요인으로 생각됩니다.

바이오소재 창상 피복재 시장 규모는 향후 수년간 견고한 성장이 전망됩니다. 2030년에는 86억 2,000만 달러에 달하며, CAGR은 6.7%에 달할 전망입니다. 예측 기간 중 성장 요인으로는 고령화 인구 증가와 욕창 유병률 증가, 바이오엔지니어링 및 세포 기반 피부 대체재에 대한 수요 증가, 재택 및 외래 의료에서 첨단 드레싱 채택 증가, 치유 기간 단축 및 치료 시간 단축에 대한 관심 증가, 생체 재료 상처 드레싱의 구성 및 디자인의 지속적인 기술 혁신을 들 수 있습니다. 예측 기간의 주요 동향으로는 고급 보습성 창상피복재 선호도 증가, 항균-항미생물성 바이오소재 피복재 채용 확대, 만성창상-화상-욕창 관리 분야에서의 사용 증가, 수술 및 수술 후 관리에서의 바이오소재 피복재 보급 확대, 생체적합성, 편안함, 조직 재생 기능 강화에 대한 관심 증가 등을 꼽을 수 있습니다. 꼽을 수 있습니다.

향후 수년간 수술 건수 증가는 바이오소재 상처 드레싱 시장의 성장을 촉진할 것으로 예측됩니다. 수술은 질병, 외상 또는 변형을 치료하기 위해 신체에 절개를 가하여 조직을 복구, 절제 또는 교정하는 의료적 개입을 말합니다. 수술 건수 증가는 만성질환 유병률 증가, 의료보험 접근성 향상, 의료관광 확대, 의료분야의 발전 등에 기인합니다. 바이오소재 창상피복재는 병원균에 대한 장벽 역할을 하여 수술 부위를 보호하고 수술 부위 감염(SSI)의 위험을 줄입니다. 예를 들어 호주의 보건복지 통계기관인 호주보건복지연구원(AIHW)에 따르면 2025년 5월 기준 공립병원의 2023-24년도 선택적 수술 환자 수는 778,500명으로 2022-23년도에 비해 5.8% 증가할 것으로 예상했습니다. 따라서 수술 건수 증가는 바이오소재 상처 드레싱 시장의 성장에 기여하고 있습니다.

생체 재료 상처 드레싱 시장의 주요 기업은 보다 효과적이고 편리한 솔루션으로 표적화된 상처 치료법 개발에 주력하고 있습니다. 표적 상처 치료는 다양한 유형의 상처에 대한 특정 요구를 충족시키기 위해 고안된 개별화된 의료 요법입니다. 예를 들어 캘리포니아 공대 연구진은 2023년 3월 당뇨병성 궤양과 같은 만성 감염성 상처의 치유를 촉진하는 '스마트 밴디지'를 발표했습니다. 이 붕대는 전자기기와 약물이 내장된 유연하고 탄력적인 폴리머로 만들어졌습니다. 센서가 장착되어 있으며, 요산, 젖산, pH, 온도 등의 지표를 모니터링하여 염증과 감염을 감지할 수 있습니다. 또한 약물이 함유된 하이드로겔을 이용하여 항생제 및 기타 치료제를 상처 부위에 직접 전달할 가능성이 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA
영문 목차

영문목차

Biomaterial wound dressings are wound care products crafted from natural or synthetic materials that are compatible with the human body. These dressings are intended to cover and safeguard wounds, promote healing, and create an appropriate environment for tissue regeneration. They can vary in composition and structure, with some incorporating advanced features such as antibacterial properties, moisture retention capabilities, and the ability to conform to the wound site for optimal healing.

The main types of biomaterial wound dressings include hydrogel dressings, alginate dressings, hydrocolloid dressings, and skin substitutes. Hydrogel dressings consist of a network of hydrophilic polymers that can retain significant amounts of water, fostering a moist environment conducive to wound healing. They find applications in various scenarios such as burns, pressure ulcers, surgical wounds, lacerations, cuts, and skin grafts, and are utilized by various end users such as hospitals, clinics, ambulatory surgical centers, and homecare settings.

Tariffs are impacting the biomaterial wound dressing market by increasing costs for polymer films, hydrogel materials, alginate fibers, antimicrobial additives, and sterile packaging components that are sourced through globally distributed supply chains, resulting in higher production and import costs. The effect is most pronounced across alginate dressings, hydrocolloid products, and bioengineered skin substitutes manufactured in Asia-Pacific and European hubs where specialty biomaterial inputs are tariff sensitive. Hospitals and clinics, ambulatory surgical centers, and homecare settings are experiencing pricing pressures and extended procurement cycles as tariff-driven costs are passed along the value chain. However, tariffs are also encouraging regional manufacturing, localized sourcing of biomaterial inputs, and domestic product assembly, which may strengthen supply resilience and support long-term industry investment.

The biomaterial wound dressing market research report is one of a series of new reports from The Business Research Company that provides biomaterial wound dressing market statistics, including biomaterial wound dressing industry global market size, regional shares, competitors with a biomaterial wound dressing market share, detailed biomaterial wound dressing market segments, market trends and opportunities, and any further data you may need to thrive in the biomaterial wound dressing industry. This biomaterial wound dressing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biomaterial wound dressing market size has grown strongly in recent years. It will grow from $6.18 billion in 2025 to $6.65 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rise in incidence of burns and traumatic injuries, increasing hospital admissions for chronic and diabetic wounds, early adoption of hydrogel and alginate dressing technologies, growing emphasis on infection prevention and moisture-balanced healing, expansion of wound care services across hospitals and clinics.

The biomaterial wound dressing market size is expected to see strong growth in the next few years. It will grow to $8.62 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing aging population and prevalence of pressure ulcers, rising demand for bioengineered and cellular skin substitutes, higher adoption of advanced dressings in homecare and ambulatory care, growing focus on faster healing and reduced treatment time, continuous innovation in biomaterial wound dressing composition and design. Major trends in the forecast period include increasing preference for advanced moisture-retentive wound dressings, rising adoption of antibacterial and antimicrobial biomaterial dressings, growing utilization in chronic wound, burn, and pressure ulcer management, expansion of biomaterial dressings in surgical and post-operative care, focus on biocompatibility, comfort, and enhanced tissue regeneration.

The increasing number of surgical procedures is expected to drive the growth of the biomaterial wound dressing market in the coming years. Surgery refers to a medical intervention that involves making incisions in the body to treat diseases, injuries, or deformities by repairing, removing, or modifying tissue. The rise in surgical procedures is attributed to a growing prevalence of chronic diseases, improved access to health insurance, expanding medical tourism, and advancements in the healthcare sector. Biomaterial wound dressings help protect surgical sites by acting as a barrier against pathogens, thereby reducing the risk of surgical site infections (SSIs). For example, in May 2025, according to the Australian Institute of Health and Welfare (AIHW), an Australia-based organization providing health and welfare statistics, public hospitals admitted 778,500 elective surgery patients in 2023-24, reflecting a 5.8% year-on-year increase compared with 2022-23. Therefore, the rising volume of surgeries is contributing to the growth of the biomaterial wound dressing market.

Key players in the biomaterial wound dressing market are focusing on developing targeted wound treatments for more effective and convenient solutions. Targeted wound treatments are tailored medical therapies designed to meet the specific needs of different types of wounds. For instance, researchers from the California Institute of Technology introduced the Smart Bandage in March 2023, which accelerates the healing of chronic infected wounds such as diabetic ulcers. These bandages are made from a flexible, elastic polymer embedded with electronics and drugs. Equipped with sensors, they can detect inflammation and infection by monitoring indicators such as uric acid, lactate, pH, and temperature. Additionally, they can deliver antibiotics or other treatments directly to the wound site using drug-loaded hydrogels.

In November 2024, BioStem Technologies, Inc., a US-based company engaged in the development and commercialization of placental-derived biologics, entered into a Letter of Intent to acquire wound care products and technologies from ProgenaCare Global LLC for an undisclosed amount. Through this transaction, BioStem aimed to broaden its wound care offerings by incorporating complementary biomaterial-based products into its existing commercial platform. ProgenaCare Global LLC is a US-based medical technology company specializing in advanced wound care biomaterials, including products such as ProgenaMatrix and Revyve.

Major companies operating in the biomaterial wound dressing market are Johnson & Johnson, The 3M Company, Medline Industries LP, B. Braun SE, Smith & Nephew plc, Milliken Healthcare Products LLC, Coloplast A/S, Molnlycke Health Care AB, Integra LifeSciences, Lohmann & Rauscher International GmbH & Co. KG, Hollister Incorporated, DeRoyal Industries Inc., Advanced Medical Solutions Group, URGO MEDICAL, BSN Medical, Gentell, Dukal LLC, Covalon Technologies, Argentum Medical LLC, PolyMedics Innovations Inc., Spenco Medical Corporation

North America was the largest region in the biomaterial wound dressing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomaterial wound dressing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biomaterial wound dressing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The biomaterial wound dressing market consists of sales of collagen dressings, chitosan dressings, silicone-based dressings, foam dressings, film dressings, and composite dressings. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biomaterial Wound Dressing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses biomaterial wound dressing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for biomaterial wound dressing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biomaterial wound dressing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Biomaterial Wound Dressing Market Characteristics

3. Biomaterial Wound Dressing Market Supply Chain Analysis

4. Global Biomaterial Wound Dressing Market Trends And Strategies

5. Biomaterial Wound Dressing Market Analysis Of End Use Industries

6. Biomaterial Wound Dressing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Biomaterial Wound Dressing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Biomaterial Wound Dressing Total Addressable Market (TAM) Analysis for the Market

9. Biomaterial Wound Dressing Market Segmentation

10. Biomaterial Wound Dressing Market Regional And Country Analysis

11. Asia-Pacific Biomaterial Wound Dressing Market

12. China Biomaterial Wound Dressing Market

13. India Biomaterial Wound Dressing Market

14. Japan Biomaterial Wound Dressing Market

15. Australia Biomaterial Wound Dressing Market

16. Indonesia Biomaterial Wound Dressing Market

17. South Korea Biomaterial Wound Dressing Market

18. Taiwan Biomaterial Wound Dressing Market

19. South East Asia Biomaterial Wound Dressing Market

20. Western Europe Biomaterial Wound Dressing Market

21. UK Biomaterial Wound Dressing Market

22. Germany Biomaterial Wound Dressing Market

23. France Biomaterial Wound Dressing Market

24. Italy Biomaterial Wound Dressing Market

25. Spain Biomaterial Wound Dressing Market

26. Eastern Europe Biomaterial Wound Dressing Market

27. Russia Biomaterial Wound Dressing Market

28. North America Biomaterial Wound Dressing Market

29. USA Biomaterial Wound Dressing Market

30. Canada Biomaterial Wound Dressing Market

31. South America Biomaterial Wound Dressing Market

32. Brazil Biomaterial Wound Dressing Market

33. Middle East Biomaterial Wound Dressing Market

34. Africa Biomaterial Wound Dressing Market

35. Biomaterial Wound Dressing Market Regulatory and Investment Landscape

36. Biomaterial Wound Dressing Market Competitive Landscape And Company Profiles

37. Biomaterial Wound Dressing Market Other Major And Innovative Companies

38. Global Biomaterial Wound Dressing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Biomaterial Wound Dressing Market

40. Biomaterial Wound Dressing Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기